Supported by National Natural Science Foundation of China (No.30572339 and No.30325045)
This article presents an integrated overview of GuanxinⅡ(冠心Ⅱ号)regarding its quality control,pharmacokinetics,pharmacology,clinical studies,adverse events,dosage and administration,and its pharmacoeconomic assessm...